246 related articles for article (PubMed ID: 9671769)
1. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53.
Pierce AM; Gimenez-Conti IB; Schneider-Broussard R; Martinez LA; Conti CJ; Johnson DG
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8858-63. PubMed ID: 9671769
[TBL] [Abstract][Full Text] [Related]
2. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development.
Pierce AM; Fisher SM; Conti CJ; Johnson DG
Oncogene; 1998 Mar; 16(10):1267-76. PubMed ID: 9546428
[TBL] [Abstract][Full Text] [Related]
3. E2F4 and E2F1 have similar proliferative properties but different apoptotic and oncogenic properties in vivo.
Wang D; Russell JL; Johnson DG
Mol Cell Biol; 2000 May; 20(10):3417-24. PubMed ID: 10779331
[TBL] [Abstract][Full Text] [Related]
4. E2F1 has both oncogenic and tumor-suppressive properties in a transgenic model.
Pierce AM; Schneider-Broussard R; Gimenez-Conti IB; Russell JL; Conti CJ; Johnson DG
Mol Cell Biol; 1999 Sep; 19(9):6408-14. PubMed ID: 10454586
[TBL] [Abstract][Full Text] [Related]
5. Myc lacks E2F1's ability to suppress skin carcinogenesis.
Rounbehler RJ; Schneider-Broussard R; Conti CJ; Johnson DG
Oncogene; 2001 Aug; 20(38):5341-9. PubMed ID: 11536046
[TBL] [Abstract][Full Text] [Related]
6. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors.
Pan H; Yin C; Dyson NJ; Harlow E; Yamasaki L; Van Dyke T
Mol Cell; 1998 Sep; 2(3):283-92. PubMed ID: 9774967
[TBL] [Abstract][Full Text] [Related]
7. E2F1 mediates ectopic proliferation and stage-specific p53-dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses.
Liu Y; Zacksenhaus E
Oncogene; 2000 Dec; 19(52):6065-73. PubMed ID: 11146559
[TBL] [Abstract][Full Text] [Related]
8. E2F-1-induced p53-independent apoptosis in transgenic mice.
Holmberg C; Helin K; Sehested M; Karlström O
Oncogene; 1998 Jul; 17(2):143-55. PubMed ID: 9674698
[TBL] [Abstract][Full Text] [Related]
9. Deregulated expression of DP1 induces epidermal proliferation and enhances skin carcinogenesis.
Wang D; Russell J; Xu H; Johnson DG
Mol Carcinog; 2001 Jun; 31(2):90-100. PubMed ID: 11429786
[TBL] [Abstract][Full Text] [Related]
10. Regulation of BRCA1 expression by the Rb-E2F pathway.
Wang A; Schneider-Broussard R; Kumar AP; MacLeod MC; Johnson DG
J Biol Chem; 2000 Feb; 275(6):4532-6. PubMed ID: 10660629
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
Rounbehler RJ; Rogers PM; Conti CJ; Johnson DG
Cancer Res; 2002 Jun; 62(11):3276-81. PubMed ID: 12036945
[TBL] [Abstract][Full Text] [Related]
12. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
Chen Q; Hung FC; Fromm L; Overbeek PA
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619
[TBL] [Abstract][Full Text] [Related]
13. E2F as a regulator of keratinocyte proliferation: implications for skin tumor development.
Jones SJ; Dicker AJ; Dahler AL; Saunders NA
J Invest Dermatol; 1997 Aug; 109(2):187-93. PubMed ID: 9242506
[TBL] [Abstract][Full Text] [Related]
14. A role for E2F1 in the induction of ARF, p53, and apoptosis during thymic negative selection.
Zhu JW; DeRyckere D; Li FX; Wan YY; DeGregori J
Cell Growth Differ; 1999 Dec; 10(12):829-38. PubMed ID: 10616908
[TBL] [Abstract][Full Text] [Related]
15. Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice.
Wikonkal NM; Remenyik E; Knezevic D; Zhang W; Liu M; Zhao H; Berton TR; Johnson DG; Brash DE
Nat Cell Biol; 2003 Jul; 5(7):655-60. PubMed ID: 12833065
[TBL] [Abstract][Full Text] [Related]
16. Role of the p53-homologue p73 in E2F1-induced apoptosis.
Stiewe T; Pützer BM
Nat Genet; 2000 Dec; 26(4):464-9. PubMed ID: 11101847
[TBL] [Abstract][Full Text] [Related]
17. The role of the transcription factor DP in apoptosis.
Hitchens MR; Robbins PD
Apoptosis; 2003 Oct; 8(5):461-8. PubMed ID: 12975577
[TBL] [Abstract][Full Text] [Related]
18. Overproduction of MDM2 in vivo disrupts S phase independent of E2F1.
Reinke V; Bortner DM; Amelse LL; Lundgren K; Rosenberg MP; Finlay CA; Lozano G
Cell Growth Differ; 1999 Mar; 10(3):147-54. PubMed ID: 10099828
[TBL] [Abstract][Full Text] [Related]
19. Functional interplay between p53 and E2F through co-activator p300.
Lee CW; Sørensen TS; Shikama N; La Thangue NB
Oncogene; 1998 May; 16(21):2695-710. PubMed ID: 9652736
[TBL] [Abstract][Full Text] [Related]
20. Human ARF binds E2F1 and inhibits its transcriptional activity.
Eymin B; Karayan L; Séité P; Brambilla C; Brambilla E; Larsen CJ; Gazzéri S
Oncogene; 2001 Mar; 20(9):1033-41. PubMed ID: 11314038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
